HealthLeaders Media November 30, 2022
HHS released a proposed rule outlining changes it wishes to make to the 340B administrative dispute resolution process.
HHS issued a new proposed rule revising the 2020 final rule that established the 340B administrative dispute resolution (ADR) process to better align with requirements found within the Affordable Care Act.
For background, the 340B program requires drug manufacturers to provide outpatient drugs to eligible healthcare organizations and other covered entities at significantly reduced prices. The ADR process is an administrative process designed to assist these organizations and manufacturers in resolving disputes regarding overcharging, duplicate discounts, or diversion.
340B payments are a lifeline for some organizations, making the ADR process that much more important as hospitals need to ensure fair and accurate...
Today's Sponsors
Today's Sponsor